Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: a case-control study and a meta-analysis.
内皮型一酸化窒素合成酵素遺伝子多型(Glu298Asp)と子癇前症の発症:症例対照研究およびメタ分析 (機械翻訳の邦題)
記録の確認項目
- 研究デザイン
- その他の原著論文
- 対象
- 未確定
- 出版年
- 2006
- 出典
- doi.org
- 抄録の表示
- 表示あり
- 出版状態
- 有効な記録
- 状態確認日
- 2026/08/17
- 収集日
- 2026/08/03
- 鮮度
- 確認期限内
- 確認段階
- 自動処理
- 記録状態
- 公開
日本語要約(機械生成)
子癇前症には遺伝的要因が関与すると考えられている。本研究では、eNOS遺伝子Glu298Asp多型と子癇前症の関連を検討するため、ロンドンの7つの総合病院で単胎妊娠の健康な女性を対象に症例対照研究を行い、さらに2005年11月までの既発表研究を対象にメタ分析を実施した。新規研究では子癇前症89例と対照349例を解析し、劣性モデルで有意な関連は認められなかった(調整オッズ比0.83、95%信頼区間0.30-2.25、p=0.7)。メタ分析では、劣性モデル(症例1129、対照2384)でAsp298ホモ接合体のリスク増加は有意でなく(オッズ比1.28、95%信頼区間0.76-2.16、p=0.34)、優性モデル(症例1334、対照2894)でも保因者のリスク増加は認められなかった(オッズ比1.12、95%信頼区間0.84-1.49、p=0.42)。結論として、現在のデータではeNOS Glu298Asp多型は子癇前症の有意なリスク増加と関連しないが、既存研究は検出力が低く、より大規模な研究が必要である。
この要約は公開抄録のみを根拠にAIが機械的に生成したものです。正確な内容は原文を確認してください。
抄録
Background: Pre-eclampsia is thought to have an important genetic component. Recently, pre-eclampsia has been associated in some studies with carriage of a common eNOS gene Glu298Asp polymorphism, a variant that leads to the replacement of glutamic acid by aspartic acid at codon 298.Method: Healthy women with singleton pregnancies were recruited from 7 district general hospitals in London, UK. Women at high risk of pre-eclampsia were screened by uterine artery Doppler velocimetry at 22-24 weeks of gestation and maternal blood was obtained to genotype the eNOS Glu298Asp polymorphism. Odds ratios (OR) and 95%CI, using logistic regression methods, were obtained to evaluate the association between the Glu298Asp polymorphism and pre-eclampsia. A meta-analysis was then undertaken of all published studies up to November 2005 examining the association of eNOS Glu298Asp genotype and pre-eclampsia.Results: 89 women with pre-eclampsia and 349 controls were included in the new study. The Glu298Asp polymorphism in a recessive model was not significantly associated with pre-eclampsia (adjusted-OR: 0.83 [95%CI: 0.30-2.25]; p = 0.7). In the meta-analysis, under a recessive genetic model (1129 cases & 2384 controls) women homozygous for the Asp298 allele were not at significantly increased risk of pre-eclampsia (OR: 1.28 [95%CI: 0.76-2.16]; p = 0.34). A dominant model (1334 cases & 2894 controls) was associated with no increase of risk of pre-eclampsia for women carriers of the Asp298 allele (OR: 1.12 [95%CI: 0.84-1.49]; p = 0.42).Conclusion: From the data currently available, the eNOS Glu298Asp polymorphism is not associated with a significant increased risk of pre-eclampsia. However, published studies have been underpowered, much larger studies are needed to confirm or refute a realistic genotypic risk of disease, but which might contribute to many cases of pre-eclampsia in the population.
DOI 10.1186/1471-2393-6-7
PMID 16542455
原文・出典を見る →